Agilent Technologies, Inc. $A Shares Purchased by Amundi

Amundi increased its stake in Agilent Technologies, Inc. (NYSE:A - Free Report) by 20.3% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,294,098 shares of the medical research company's stock after acquiring an additional 218,514 shares during the quarter. Amundi owned approximately 0.46% of Agilent Technologies worth $171,891,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Bank of Nova Scotia purchased a new position in Agilent Technologies in the 2nd quarter worth approximately $58,539,000. Dudley & Shanley Inc. boosted its stake in Agilent Technologies by 25.9% during the second quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company's stock worth $9,232,000 after buying an additional 14,300 shares during the last quarter. BIP Wealth LLC purchased a new stake in Agilent Technologies in the 2nd quarter valued at $834,000. Capricorn Fund Managers Ltd acquired a new stake in shares of Agilent Technologies in the 1st quarter worth $8,161,000. Finally, KBC Group NV increased its stake in shares of Agilent Technologies by 18.4% in the 2nd quarter. KBC Group NV now owns 81,883 shares of the medical research company's stock worth $10,877,000 after acquiring an additional 12,719 shares during the last quarter. Institutional investors and hedge funds own 87.41% of the company's stock.

Analyst Upgrades and Downgrades

A has been the subject of several recent analyst reports. HSBC cut their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a "buy" rating for the company in a research report on Wednesday, June 3rd. Sanford C. Bernstein upped their price target on Agilent Technologies from $155.00 to $180.00 and gave the company an "outperform" rating in a research note on Thursday, August 27th. Citigroup increased their price target on Agilent Technologies from $185.00 to $190.00 and gave the stock a "buy" rating in a report on Thursday, August 27th. JPMorgan Chase & Co. increased their target price on shares of Agilent Technologies from $180.00 to $190.00 and gave the stock an "overweight" rating in a research note on Thursday, August 27th. Finally, The Goldman Sachs Group lifted their price target on shares of Agilent Technologies from $155.00 to $175.00 and gave the company a "buy" rating in a research report on Thursday, August 27th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and four have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $170.33.

Agilent Technologies Stock Performance

Shares of A opened at $146.80 on Wednesday. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $163.75. The stock has a market capitalization of $41.39 billion, a PE ratio of 28.90, a PEG ratio of 2.30 and a beta of 1.24. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.56 and a current ratio of 2.05. The stock has a 50-day simple moving average of $142.90 and a 200-day simple moving average of $128.22.

Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, topping the consensus estimate of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The company had revenue of $1.88 billion during the quarter, compared to analysts' expectations of $1.84 billion. During the same quarter in the previous year, the business posted $1.37 EPS. The firm's revenue was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, analysts predict that Agilent Technologies, Inc. will post 6.2 earnings per share for the current fiscal year.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.